Qube Research & Technologies LTD Bristol Myers Squibb CO Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Qube Research & Technologies LTD holds 9,752,683 shares of BMY stock, worth $474 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
9,752,683
Previous 159,800
6003.06%
Holding current value
$474 Million
Previous $9.75 Million
4532.17%
% of portfolio
0.48%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding BMY
# of Institutions
2,667Shares Held
1.56BCall Options Held
23.1MPut Options Held
24.5M-
Vanguard Group Inc Valley Forge, PA196MShares$9.53 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.72 Billion0.15% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.61 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.19 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.55 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $103B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...